Company’s 36-month beta value is -0.01.Analysts have differing opinions on the stock, with 2 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for NUTX is 3.11M, and currently, short sellers hold a 1.15% ratio of that floaft. The average trading volume of NUTX on November 13, 2024 was 74.13K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
NUTX) stock’s latest price update
Nutex Health Inc (NASDAQ: NUTX)’s stock price has gone rise by 34.58 in comparison to its previous close of 27.91, however, the company has experienced a 50.24% increase in its stock price over the last five trading days. seekingalpha.com reported 2024-11-08 that Nutex Health Inc. (NASDAQ:NUTX ) Q3 2024 Earnings Conference Call November 8, 2024 10:30 AM ET Company Participants Vivian Sanders – Corporate Director of Marketing and Business Development Tom Vo – Chairman and Chief Executive Officer Jon Bates – Chief Financial Officer Warren Hosseinion – President Josh DeTillio – Chief Operating Office Conference Call Participants Bill Sutherland – The Benchmark Company Tom McGovern – Maxim Operator Greetings, and welcome to the Nutex Health Inc. Third Quarter 2024 Financial Results Conference Call. [Operator Instructions] It is now my pleasure to introduce your host, Vivian Sanders.
NUTX’s Market Performance
NUTX’s stock has risen by 50.24% in the past week, with a monthly rise of 94.61% and a quarterly rise of 189.81%. The volatility ratio for the week is 20.83% while the volatility levels for the last 30 days are 12.01% for Nutex Health Inc The simple moving average for the past 20 days is 49.56% for NUTX’s stock, with a 168.78% simple moving average for the past 200 days.
Analysts’ Opinion of NUTX
Maxim Group, on the other hand, stated in their research note that they expect to see NUTX reach a price target of $45. The rating they have provided for NUTX stocks is “Buy” according to the report published on September 18th, 2024.
Northland Capital gave a rating of “Outperform” to NUTX, setting the target price at $3 in the report published on February 22nd of the previous year.
NUTX Trading at 63.31% from the 50-Day Moving Average
After a stumble in the market that brought NUTX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -5.86% of loss for the given period.
Volatility was left at 12.01%, however, over the last 30 days, the volatility rate increased by 20.83%, as shares surge +74.94% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +77.42% upper at present.
During the last 5 trading sessions, NUTX rose by +50.24%, which changed the moving average for the period of 200-days by +96.70% in comparison to the 20-day moving average, which settled at $25.11. In addition, Nutex Health Inc saw 39.11% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at NUTX starting from Bates Jon Christian, who purchase 1,350 shares at the price of $21.46 back on Aug 22 ’24. After this action, Bates Jon Christian now owns 2,277 shares of Nutex Health Inc, valued at $28,970 using the latest closing price.
DeTillio Joshua, the Chief Operating Officer of Nutex Health Inc, purchase 1,300 shares at $17.85 during a trade that took place back on Aug 19 ’24, which means that DeTillio Joshua is holding 4,233 shares at $23,205 based on the most recent closing price.
Stock Fundamentals for NUTX
Current profitability levels for the company are sitting at:
- 0.12 for the present operating margin
- 0.28 for the gross margin
The net margin for Nutex Health Inc stands at -0.11. The total capital return value is set at 0.03. Equity return is now at value -54.71, with -8.96 for asset returns.
Based on Nutex Health Inc (NUTX), the company’s capital structure generated 0.79 points at debt to capital in total, while cash flow to debt ratio is standing at 0.08. The debt to equity ratio resting at 3.76. The interest coverage ratio of the stock is 1.79.
Currently, EBITDA for the company is -14.58 million with net debt to EBITDA at 41.13. When we switch over and look at the enterprise to sales, we see a ratio of 3.2. The receivables turnover for the company is 1.26for trailing twelve months and the total asset turnover is 0.18. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.77.
Conclusion
In a nutshell, Nutex Health Inc (NUTX) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
